Incheon, South Korea

HyunJoo Lee

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Celltrion Inc.. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: HyunJoo Lee. Retrieved from https://idiyas.com/inventor/hyunjoo-lee-c4f7wzif

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of HyunJoo Lee in Recombinant Protein Production

Introduction

HyunJoo Lee is an accomplished inventor based in Incheon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 2 patents, his work focuses on improving the efficiency and effectiveness of cell line selection and protein production.

Latest Patents

HyunJoo Lee's latest patents include a method for selecting a high expression recombinant cell line. This invention relates to a method of selecting high producer clones by utilizing an expression vector. The expression vector comprises a gene expression cassette with a selectable marker gene linked to polyA and another gene expression cassette encoding a recombinant protein of interest. This innovative method allows for the selection of high producer clones from cell populations at least 10 times fewer than existing methods. It also enables the use of a lower concentration of MTX compared to conventional gene amplification strategies, thereby shortening the development period of cell lines and reducing labor and costs.

Another notable patent is for a human host cell designed for producing recombinant proteins with high quality and quantity. This invention involves a human host cell generated from the fusion of a human embryonic kidney-derived cell and a human B-cell-derived cell through genetic engineering techniques. The stable characteristics of this human host cell make it an efficient tool for producing heterologous desired recombinant protein-based pharmaceuticals.

Career Highlights

HyunJoo Lee is currently employed at Celltrion Inc., a leading biopharmaceutical company. His work at Celltrion focuses on advancing biotechnological methods for protein production, contributing to the company's mission of developing innovative therapies.

Collaborations

HyunJoo Lee collaborates with several talented individuals in his field, including MinSeok Chang, who is also known as Min Seok Chang. Their teamwork enhances the research and development efforts at Celltrion Inc., fostering innovation in recombinant protein production.

Conclusion

HyunJoo Lee's contributions to biotechnology through his patents and work at Celltrion Inc. highlight his role as a key innovator in the field of recombinant protein production. His inventions not only improve efficiency but also pave the way for advancements in pharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…